“EVAMS – Emerging Voices in Cancer Research: A Multidisciplinary Symposium”

 

EVAMS – Emerging Voices in Cancer Research: A Multidisciplinary Symposium

 

The EVAMS – Emerging Voices in Cancer Research is a multidisciplinary international symposium fully committed to amplifying early-career contributions in oncology.

Born as the closing event of a Ministry-funded research project on innovative theranostic strategies targeting ALDH1A3—a key biomarker of cancer stem-like cells and a promising lever for precision diagnostics and therapy—EVAMS aims to provide a vibrant platform for young researchers at the forefront of cancer science.

Throughout the day, PhD students, postdoctoral fellows, residents, and early-career investigators will take the stage to present their original research through oral communications, flash talks, and poster sessions.

 

📄  Download the Event Flyer


SCOPE AND HIGHLIGHTS

This international event will bring together emerging talents and leading experts from diverse fields—chemistry, biochemistry, pharmacology, biotechnology, and medicine—to share and discuss cutting-edge discoveries in cancer research.

The symposium will conclude with a special focus session dedicated to Aldehyde Dehydrogenase (ALDH) as an innovative pharmacological target in brain cancer, the central topic of the co-funded research project.

 

KEY INFORMATION

📅 28 November 2025
📍University of Pisa (Google Maps link)
🎫 Free registration – but limited spots! (https://forms.office.com/e/JzkeNG41pq?origin=lprLink )
🗣️ English

 

SCIENTIFIC PROGRAMME

📄 Download the Full Programme

The Scientific Programme includes:
4 Keynote Lectures by international speakers:

Prof Mattia Mori – University of Siena

Prof Gennara Cavallaro – University of Palermo

 Prof Sara Galimberti – University of Pisa

 Dr Raquel Pequerul Pavón – Autonomous University of Barcelona

🗣️ Oral and flash communications – selected from the submitted abstracts
🧾 Poster session – featuring original work from young investigators
☕ Networking moments – connect and collaborate in a friendly, interdisciplinary atmosphere

 

08:30 09:00 REGISTRATION
09:00 09:15 OPENING ADDRESS
SESSION 1
chair Prof Concettina La Motta, University of Pisa
chair Prof Gennara Cavallaro University of Palermo
09:15 09:45 KEY1 Prof Gennara Cavallaro (University of Palermo): Multifunctional Nanoplatforms for Precision Medicine in Cancer Therapy
9:45 9:55 OR1 Dr Alexandra Charalampopoulou (The National Center for Oncological Hadrontherapy): The Role of Radiobiology in Cancer Research
9:55 10:05 OR2 Dr Marta Roncetti (Consiglio Nazionale delle Ricerche): Boosting the Anticancer Activity of Attenuated Listeria Monocytogenes via Bio-orthogonal Conjugation of Therapeutic Molecules
10:05 10:15 OR3 Dr Lidia Ciccone (University of Pisa): Human Prealbumin in Complex with Anticancer Drugs
10:15 10:25 OR4 Dr Salvatore Emanuele Drago (University of Palermo): Bioreducible Cationic Polymethacrylate-Carbon Nanodot Conjugates as Theranostic Platforms for siRNA Delivery
10:25 10:30 YT1 Dr Maria Chiara Santangelo (University of Pisa): Glycoconjugated Luminescent Ln (III) Complexes as Selective Bioimaging Probes
10:30 10:35 YT2 Dr Jacopo Castagnoli (University of Pisa): Cyclodextrin-based Nanocarrier Systems for Improved Delivery of Gefitinib in Lung Cancer Treatment
10:35 10:40 FP1 To be selected
10:40 10:45 FP2 To be selected
10:45 11:30 COFFEE BREAK AND NETWORKING
SESSION 2
chair Dr Ilaria D’Agostino, University of Pisa
chair Prof Sara Galimberti, University of Pisa
11:30 12:00 KEY2 Prof Sara Galimberti (University of Pisa): The New Frontiers of Immunotherapy in Hematology: From Bispecific Antibodies to CAR T Cells
12:00 12:10 OR5 Dr Elena Andreucci (University of Florence): New Challenges in Immuno-Oncology: How to Induce Immunogenic Cell Death and Trigger a Systemic Anti-Tumour Response
12:10 12:20 OR6 Dr Davide De Luca (Consiglio Nazionale delle Ricerche): Functional Characterization of MYC Point Mutations in Diffuse Large B-cell Lymphoma
12:20 12:30 OR7 Dr Marta Banchi (University of Pisa): Synergistic Activity of Tafasitamab and Metronomic Chemotherapy on Preclinical Models of Diffuse Large B-Cell Lymphoma
12:30 12:40 OR8 Dr Silvia Martina Ferrari (University of Pisa): New Targeted Therapies in Aggressive Thyroid Cancer for the Personalization of the Treatment
12:40 12:45 YT3 Dr Lorenzo Chiaverini (University of Pisa): Metal Complexes for Anticancer Treatment
12:45 12:50 YT4 Dr Miriana Di Stefano (University of Pisa) Artificial Intelligence and Drug Discovery
12:50 12:55 FP3 To be selected
12:55 13:00 FP4 To be selected
13:00 14:30 LIGHT LUNCH AND POSTER SESSION
SESSION 3
chair Dr Ilaria D’Agostino, University of Pisa
chair Prof Mattia Mori, University of Siena
14:30 15:00 KEY3 Prof Mattia Mori (University of Siena): A Journey into the Chemical Space of Hedgehog Pathway Inhibitors
15:00 15:10 OR9 Dr Davide Moi (University of Cagliari): Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer
15:10 15:20 OR10 Dr Doretta Cuffaro (University of Pisa): Structural Optimization and in vitro Efficacy on Colorectal Cancer Cells of Novel Cetuximab-Conjugate Aminobisphosphonates
15:20 15:30 OR11 Dr Giulia Bononi (University of Pisa): Targeting Cancer Cell Metabolism: Therapeutic and Diagnostic Approaches
15:30 15:40 OR12 Dr Andrea Angeli (University of Florence): Dual Inhibition of Carbonic Anhydrase IX and Glutathione Peroxidase 4 as a Novel Strategy for Ferroptosis-Induced Tumor Cell Death
15:40 15:45 YT5 Dr Fabio Di Ricco (University of Pisa): A Novel Class of Thyromimetics for the Treatment of MASLD-Associated HCC
15:45 15:50 YT6 Dr Eva Landucci (University of Pisa): Piperidine-Based MAGL Inhibitors: A Reversible Approach to Enzyme Modulation
15:50 15:55 FP5 To be selected
15:55 16:00 FP6 To be selected
16:00 16:30 COFFEE BREAK AND NETWORKING
SESSION 4
chair Prof Concettina La Motta, University of Pisa
chair Prof Silvia Garavaglia, University of Piemonte Orientale
    chair Prof Lorenzo Magrassi, University of Pavia
16:30 17:00 KEY4 Dr. Raquel Pequerul (Universitat Autònoma de Barcelona): Improved Detection of ALDH in Low-Activity Samples Using an Enhanced-Fluorescence Method
17:00 17:10 OR13 Dr Sneha Swaroop (University of Bradford, UK): Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer
17:10 17:20 OR14 Dr Maya MacLean (Dalhousie University): Highly selective inhibition of ALDH1A3 impedes breast cancer growth and metastasis by blocking ALDH1A3-driven transcriptional programs
17:20 17:30 OR15 Dr Bianca Laura Bernardoni (University of Pisa): Lighting Up Cancer: Design and Synthesis of Fluorescent ALDH1A3 Inhibitors for Precision Cancer Surgery
17:30 17:40 OR16 Dr Paola Corna (University of Pavia): Biological Effects of ALDH1A3 Ligands Containing B or Gd on Glioblastoma cells
17:40 17:50 OR17 Dr Valentina Gigliotti (University of Piemonte Orientale): A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroids Growth and Neutrophil Recruitment
17:50 18:00 OR18 Dr Giulia Ferrara (University of Piemonte Orientale): ALDH1A3-Targeted Theranostics
18:00 18:10 OR19 Dr Manuel Giacomarra (Fondazione Pisana per la Scienza): Exploring a Novel ALDH Inhibitor as a Promising Anticancer Agent against Glioblastoma Using in Vitro Precision Medicine Approaches
18:10 18:30 CLOSING REMARKS AND POSTER PRIZES

 

VENUE AND INFORMATION

The symposium will be a FREE EVENT and is scheduled for November 28th, 2025

The EVAMS will be held at the University of Pisa

The official language of the Symposium is English

Deadline for Registration – SPOTS ARE LIMITED, so Hurry up!!!

Deadline for Abstract Submission: November 21st

 

ACTIVE PARTICIPATION

All attendees are warmly encouraged to present their anticancer research project by submitting an abstract using the official template file.

📄 Download Abstract Template

 

Abstract Submission Deadline: November 21st, 2025

Notification of Flash Talk Selection: November 24th, 2025

The Best Poster Award will be announced during the closing session.

All accepted abstracts will be included in the official EVAMS Book of Abstracts.

📄 Download EVAMS Book of Abstracts

 

👉 Register now – limited seats!  📲 https://forms.office.com/e/JzkeNG41pq?origin=lprLink

 

SCIENTIFIC COMMITTEE

Prof Concettina La Motta – University of Pisa

Dr Ilaria D’Agostino – University of Pisa

Prof Silvia Garavaglia – University of Eastern Piedmont

Prof Lorenzo Magrassi – University of Pavia

 

ACKNOWLEDGEMENTS and SPONSORS

 

🌱 Organized in full compliance with the Gender Equality Guidelines for Conferences and the Guidelines for Sustainable Events.

 

🙏Funded by the European Union – Next Generation EU, Mission 4, Component 2, Investment 1.1, CUP I53D23004870006

 

🙏 Co-funded by the University of Pisa – Conference Funding Call 2025

 

Sponsored by Zentek (https://zentek.it/)

 

Join Us!

Join us for the EVAMS!
🚨 Don’t miss this opportunity – 🎤 Your Research deserves to be heard!

Torna in cima